Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates - Iowa Capital Dispatch
Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates Iowa Capital Dispatch
Hodgkin Lymphoma News
Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates - Ottumwa Courier
Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates Ottumwa Courier
Monsanto Roundup Lawsuit | March 2026 Update & Settlement - Lawsuit Information Center
Monsanto Roundup Lawsuit | March 2026 Update & Settlement Lawsuit Information Center
Young mother’s Hodgkin lymphoma diagnosis felt ‘devastating’ - Fred Hutchinson Cancer Center
Young mother’s Hodgkin lymphoma diagnosis felt ‘devastating’ Fred Hutchinson Cancer Center
Primary non-Hodgkin lymphoma in the muscle of left lower extremity: a case report and literature review - Frontiers
Primary non-Hodgkin lymphoma in the muscle of left lower extremity: a case report and literature review Frontiers
Non-Hodgkin lymphoma survivor thankful for clinical trial - UT MD Anderson
Non-Hodgkin lymphoma survivor thankful for clinical trial UT MD Anderson
Durable 3-Year Superiority of N-AVD in Advanced Hodgkin Lymphoma - Targeted Oncology
Durable 3-Year Superiority of N-AVD in Advanced Hodgkin Lymphoma Targeted Oncology
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors - Nature
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors Nature
Hodgkin lymphoma (Hodgkin disease) - Mayo Clinic
Hodgkin lymphoma (Hodgkin disease) Mayo Clinic
Miami F Marcus Allen has non-Hodgkin lymphoma, out for season - ESPN
Miami F Marcus Allen has non-Hodgkin lymphoma, out for season ESPN
Nivolumab Plus AVD Reduces Disease Progression Risk in Adolescents With Advanced Classical Hodgkin Lymphoma - The ASCO Post
Nivolumab Plus AVD Reduces Disease Progression Risk in Adolescents With Advanced Classical Hodgkin Lymphoma The ASCO Post
Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era - CancerNetwork
Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era CancerNetwork
Breast Cancer Risk After Chest Radiotherapy in Hodgkin Lymphoma Survivors: A Comprehensive Overview - ScienceDirect.com
Breast Cancer Risk After Chest Radiotherapy in Hodgkin Lymphoma Survivors: A Comprehensive Overview ScienceDirect.com
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy - UT MD Anderson
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy UT MD Anderson
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma - Nature
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma Nature
Low-Dose Nivolumab Offers Novel Strategy for Hodgkin Lymphoma Treatment - Targeted Oncology
Low-Dose Nivolumab Offers Novel Strategy for Hodgkin Lymphoma Treatment Targeted Oncology
Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about UT MD Anderson coming to Austin - UT MD Anderson
Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about UT MD Anderson coming to Austin UT MD Anderson
Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial - Nature
Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial Nature
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials - Nature
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials Nature
Learn About How Survival Rates Are Improving With Hodgkin Disease - Verywell Health
Learn About How Survival Rates Are Improving With Hodgkin Disease Verywell Health
Impact of early failure of induction on transplant outcomes in Hodgkin lymphoma | Bone Marrow Transplantation - Nature
Impact of early failure of induction on transplant outcomes in Hodgkin lymphoma | Bone Marrow Transplantation Nature
An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma - NEJM Evidence
An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma NEJM Evidence
Axi-Cel Shows Durable Responses, Curative Hope in Non-Hodgkin Lymphoma - Targeted Oncology
Axi-Cel Shows Durable Responses, Curative Hope in Non-Hodgkin Lymphoma Targeted Oncology
First-Line Options in Advanced-Stage Classical Hodgkin Lymphoma: Weighing Efficacy, Toxicity, and Quality of Life in Decision-Making - ASCO Daily News
First-Line Options in Advanced-Stage Classical Hodgkin Lymphoma: Weighing Efficacy, Toxicity, and Quality of Life in Decision-Making ASCO Daily News
An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma - NEJM Evidence
An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma NEJM Evidence
Treatment of relapsed or refractory Hodgkin’s lymphoma with lenalidomide combined with PD-1 monoclonal antibody: a case report and literature review - Frontiers
Treatment of relapsed or refractory Hodgkin’s lymphoma with lenalidomide combined with PD-1 monoclonal antibody: a case report and literature review Frontiers
Vanishing Bile Duct Syndrome as a Rare Complication of Classic Hodgkin's Lymphoma: A Case Report and Literature Review - Cureus
Vanishing Bile Duct Syndrome as a Rare Complication of Classic Hodgkin's Lymphoma: A Case Report and Literature Review Cureus
Clinical features and outcomes of newly diagnosed classical Hodgkin lymphoma patients in Saudi Arabia: a multicenter cohort study | Scientific Reports - Nature
Clinical features and outcomes of newly diagnosed classical Hodgkin lymphoma patients in Saudi Arabia: a multicenter cohort study | Scientific Reports Nature
Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older Patients - ASCO Publications
Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older Patients ASCO Publications
Cancer Drug Tazemetostat (Tazverik) Pulled Due to Safety Concerns - Oncology News Central
Cancer Drug Tazemetostat (Tazverik) Pulled Due to Safety Concerns Oncology News Central
‘The Sister Act’: How family and faith helped a young woman beat Hodgkin’s lymphoma - University of California - Davis Health
‘The Sister Act’: How family and faith helped a young woman beat Hodgkin’s lymphoma University of California - Davis Health
New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients - Roswell Park Comprehensive Cancer Center
New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients Roswell Park Comprehensive Cancer Center
Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank - Wiley Online Library
Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank Wiley Online Library
Non-Hodgkin's Lymphoma in Pregnancy: A Report of a Rare Case - Cureus
Non-Hodgkin's Lymphoma in Pregnancy: A Report of a Rare Case Cureus
‘Elevated’ Hodgkin’s lymphoma numbers among teens at Medina High School - Cleveland 19 News
‘Elevated’ Hodgkin’s lymphoma numbers among teens at Medina High School Cleveland 19 News
Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-up of ZUMA-5 - The ASCO Post
Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-up of ZUMA-5 The ASCO Post
Subgroup analysis of treatment pathways and clinical outcomes in Hodgkin lymphoma in Latin America from the retrospective B-HOLISTIC study - Nature
Subgroup analysis of treatment pathways and clinical outcomes in Hodgkin lymphoma in Latin America from the retrospective B-HOLISTIC study Nature
Groundbreaking treatment fighting back against Non-Hodgkin’s Lymphoma - KPLC 7 News
Groundbreaking treatment fighting back against Non-Hodgkin’s Lymphoma KPLC 7 News
Population based analysis of twenty year incidence trends of pediatric Hodgkin lymphoma in the United States - Nature
Population based analysis of twenty year incidence trends of pediatric Hodgkin lymphoma in the United States Nature
Sintilimab combined with AVD for the treatment of composite Hodgkin lymphoma and follicular lymphoma: a case report and literature review - Frontiers
Sintilimab combined with AVD for the treatment of composite Hodgkin lymphoma and follicular lymphoma: a case report and literature review Frontiers